Stratos Wealth Partners LTD. Sells 336 Shares of Aflac Incorporated (NYSE:AFL)

Stratos Wealth Partners LTD. decreased its position in Aflac Incorporated (NYSE:AFL) by 1.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 29,497 shares of the financial services provider’s stock after selling 336 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Aflac were worth $2,434,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Fortitude Family Office LLC acquired a new stake in shares of Aflac in the fourth quarter worth $25,000. CoreFirst Bank & Trust acquired a new stake in Aflac during the fourth quarter worth $25,000. Studio Investment Management LLC acquired a new stake in Aflac during the fourth quarter worth $27,000. Impact Partnership Wealth LLC boosted its stake in Aflac by 471.4% during the third quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider’s stock worth $31,000 after buying an additional 330 shares in the last quarter. Finally, Bruce G. Allen Investments LLC acquired a new stake in Aflac during the fourth quarter worth $32,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Insider Transactions at Aflac

In other news, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total transaction of $423,100.00. Following the completion of the transaction, the director now directly owns 17,920 shares in the company, valued at approximately $1,516,390.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total value of $423,100.00. Following the completion of the transaction, the director now directly owns 17,920 shares in the company, valued at approximately $1,516,390.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Albert Riggieri sold 8,000 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total value of $666,720.00. Following the completion of the transaction, the senior vice president now owns 32,825 shares of the company’s stock, valued at $2,735,635.50. The disclosure for this sale can be found here. In the last ninety days, insiders sold 46,493 shares of company stock worth $3,765,706. 0.90% of the stock is currently owned by company insiders.

Aflac Stock Performance

Shares of NYSE:AFL opened at $85.42 on Monday. The stock has a market capitalization of $49.15 billion, a P/E ratio of 11.02, a P/E/G ratio of 2.33 and a beta of 0.91. Aflac Incorporated has a 1-year low of $64.06 and a 1-year high of $86.26. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.33. The business has a 50-day moving average price of $81.81 and a two-hundred day moving average price of $81.23.

Aflac (NYSE:AFL) last posted its earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.47 by ($0.22). The company had revenue of $3.78 billion for the quarter, compared to analyst estimates of $4.44 billion. Aflac had a return on equity of 17.59% and a net margin of 24.92%. During the same quarter in the previous year, the firm posted $1.29 earnings per share. Equities analysts predict that Aflac Incorporated will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. StockNews.com upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research note on Thursday, March 28th. Evercore ISI downgraded shares of Aflac from an “in-line” rating to an “underperform” rating and lifted their price target for the stock from $76.00 to $78.00 in a research note on Thursday, January 4th. Raymond James lifted their price target on shares of Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a research note on Friday, February 2nd. The Goldman Sachs Group lifted their price objective on Aflac from $61.00 to $75.00 and gave the company a “sell” rating in a report on Tuesday, January 9th. Finally, Morgan Stanley cut their price objective on Aflac from $85.00 to $80.00 and set an “equal weight” rating for the company in a report on Friday, March 1st. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $81.58.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.